Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Diagnosis, treatment, and rehabilitation in patients with dizziness and cognitive impairment

https://doi.org/10.14412/2074-2711-2017-3-76-80

Full Text:

Abstract

Complaints of dizziness and instability are the common reason for seeking a neurologist's advice at an outpatient visit and can be the frequent reason for emergency hospitalization.
Difficulty in diagnosing the causes of dizziness and instability is due to a diversity of diseases manifested by these symptoms. The list of etiological factors includes peripheral and central vestibular lesions and unrelated nervous system diseases. In a number of cases, dizziness and instability are concurrent with cognitive impairment. Complaints of poor concentration and memory, dizziness and instability can often be associated with brain degenerative and/or vascular lesions, as well as with pathological mood changes and anxiety disorder.
The diagnosis of these diseases requires neurovestibular examination, cognitive testing, and assessment of the emotional status of patients. Early detection of the causes of dizziness and memory disorders ensures better treatment results. There are different approaches to therapy for dizziness and cognitive impairment: drug and non-drug correction techniques (vestibular rehabilitation and cognitive training). Biofeedback procedures were shown to be highly effective.
The effect of tanakan in treating patients with involvement of the peripheral vestibular system and brain structures is discussed

About the Author

L. M. Antonenko
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation

11, Rossolimo St., Moscow 119021

Department of Nervous System Diseases and Neurosurgery



References

1. McLellan DL. Introduction to rehabilitation. In: McLellan DL, Wilson B, editors. The Handbook of rehabilitation studies. Cambridge: Cambridge University Press; 1997. P. 1-21

2. Neuhauser HK, von Brevern M, Radtke A, et al. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology. 2005 Sep 27;65(6):898-904.

3. Парфенов ВА, Замерград МВ, Мельников ОА. Головокружение: диагностика, лечение, распространенные диагностические ошибки. Учебное пособие. Москва: МИА; 2011. 190 с. [Parfenov VA, Zamergrad MV, Mel'nikov OA. Golovokruzhenie diagnostika, lechenie, rasprostranennye diagnosticheskie oshibki. Uchebnoe posobie [Vertigo diagnosis, treatment, common diagnostic errors. Tutorial]. Moscow: MIA; 2011. 190 p.]

4. Парфенов ВА, Антоненко ЛМ. Лечение и реабилитация основных заболеваний, проявляющихся вестибулярным головокружением. Неврология, нейропсихиатрия, психосоматика. 2015;7(2):56-60. [Parfenov VA, Antonenko LM. Major diseases manifesting by vestibular vertigo: Treatment and rehabilitation. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2015;7(2):56-60. (In Russ.)]. doi: 10.14412/2074-2711-2015-2-56-60

5. Geser R, Straumann D. Referral and final diagnoses of patients assessed in an academic vertigo center. Front Neurol. 2012 Nov 28;3:169. doi: 10.3389/fneur.2012.00169. eCollection 2012.

6. Pollak L. Awareness of benign paroxysmal positional vertigo in central Israel. BMC Neurol. 2009 Apr 22;9:17. doi: 10.1186/1471-2377-9-17.

7. Dieterich M. Central vestibular disorders. J Neurol. 2007 May;254(5):559-68. Epub 2007 Apr 6.

8. Kanashiro AM, Pereira CB, Melo AC, Scaff M. Diagnosis and treatment of the most frequent vestibular syndromes. Arq Neuropsiquiatr. 2005 Mar;63(1):140-4. Epub 2005 Apr 13.

9. Arbusow V, Schulz P, Strupp M, et al. Distribution of herpes simplex virus type I in human geniculate and vestibular ganglia: implications for vestibular neuritis. Ann Neurol. 1999 Sep;46(3):416-9.

10. Bartual-Pastor J. Vestibular neuritis: etiopathogenesis. Rev Laryngol Otol Rhinol (Bord). 2005;126(4):279-81.

11. Brandt Т, Dieterich М. Vertigo and dizziness: common complains. London: Springer; 2004. 208 p.

12. Gates GA. Meniere's disease review 2005. J Am Acad Audiol. 2006 Jan;17(1):16-26.

13. Redon C, Lopez C, Bernard-Demanze L, et al. Betahistine treatment improves the recovery of static symptoms in patients with unilateral vestibular loss. J Clin Pharmacol. 2011 Apr; 51(4):538-48. doi: 10.1177/0091270010369241. Epub 2010 Oct 12.

14. Brandt T. Vertigo. Its Multisensory Syndromes. London: Springer; 2000. 504 p.

15. Замерград МВ, Мельников ОА. Болезнь Меньера. Неврологический журнал. 2011; (1):5-8. [Zamergrad MV, Mel'nikov OA. Meniere's Disease. Nevrologicheskii zhurnal. 2011;(1):5-8. (In Russ.)].

16. Semaan MT, Alagramam KN, Megerian CA. The basic science of Meniere's disease and endolymphatic hydrops. Curr Opin Otolaryngol Head Neck Surg. 2005 Oct;13(5):301-7.

17. Elble RS. Motor control and Movement Disorders. In: Jankovic J, Tolosa E, editors. Parkison's disease and Movement disorders. Baltimore: Williams & Wilkins; 1998. P. 30-5.

18. Парфенов ВА, Захаров ВВ, Преображенская ИС. Когнитивные расстройства. Москва: Ремедиум; 2014. С. 1–106. [Parfenov VA, Zakharov VV. Preobrazhenskaya IS. Kognitivnye rasstroistva [Cognitive disorders]. Moscow: Remedium; 2014. P. 1–106.]

19. Антоненко ЛМ, Дамулин ИВ. Особенности нарушений равновесия и ходьбы при болезни Паркинсона, прогрессирующем надъядерном параличе и мультисистемной атрофии. Неврологический журнал. 2005;10(3):41-50. [Antonenko LM, Damulin IV. Features of disorders of balance and walking in Parkinson's disease, progressive supranuclear palsy and multisystem atrophy. Nevrologicheskii zhurnal. 2005;10(3):41-50. (In Russ.)].

20. Брыжахина ВГ, Дамулин ИВ, Яхно НН. Нарушения ходьбы и равновесия при дисциркуляторной энцефалопатии. Неврологический журнал. 2004;9(2):11-6. [Bryzhakhina VG, Damulin IV, Yakhno NN. Disorders of walking and balance in discirculatory encephalopathy. Nevrologicheskii zhurnal. 2004;9(2):11-6. (In Russ.)].

21. Дамулин ИВ. Когнитивные расстройства сосудистого генеза: патогенетические, клинические и терапевтические аспекты. Нервные болезни. 2012;(4):14-20. [Damulin IV. Cognitive impairment of vascular origin: pathogenetic, clinical and therapeutic aspects. Nervnye bolezni. 2012;(4):14-20. (In Russ.)].

22. Bowler JV. Vascular cognitive impairment. Stroke. 2004 Feb;35(2):386-8.

23. Woelk H, Arnoldt KH, Kieser M, Hoerr R. Ginkgo biloba special extract EGb 761® in generalized anxiety disorder and adjustment disorder with anxious mood: A randomized, doubleblind, placebo-controlled trial. J Psychiatr Res. 2007 Sep;41(6):472-80. Epub 2006 Jun 30.

24. Airaksinen E. Cognitive Functions in Depression and Anxiety Disorders. Findings from a population-based study. The doctoral thesis. Stockholm; 2006.

25. Castaneda AE. Cognitive Functioning in Young Adults with Depression, Anxiety Disorders, or Burnout Symptoms. Findings from a Population-based Sample. Academic dissertation. Helsinki; 2010.

26. Парфенов ВА, Старчина ЮА, Яхно НН. Эпросартан (теветен) в профилактике повторного инсульта и когнитивных нарушений. Неврологический журнал. 2007;12(1): 46-51. [Parfenov VA, Starchina YuA, Yakhno NN Eprosartan (Teveten) in the prevention of recurrent stroke and cognitive impairment. Nevrologicheskii zhurnal. 2007;12(1):46-51. (In Russ.)].

27. Mü ller WE, Chatterjee SS. Cognitive and other behavioral effects of EGb 761® in animal models. Pharmacopsychiatry. 2003 Jun;36 Suppl 1:S24-31.

28. Sakakibara H, Ishida K, Grundmann O, et al. Antidepressant Effect of Extracts from Ginkgo biloba Leaves in Behavioral Models. Biol Pharm Bull. 2006 Aug;29(8):1767-70.

29. Bachinskaya N, Hoerr R, Ihl R. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761®. Findings from a randomized controlled trial. Neuropsychiatr Dis Treat. 2011;7:209-15. doi: 10.2147/NDT.S18741. Epub 2011 Apr 20.

30. Hoerr R. Behavioural and psychological symptoms of dementia (BPSD): effects of EGb 761®. Pharmacopsychiatry. 2003 Jun;36 Suppl 1:S56-61.

31. Величковский ББ. Возможности когнитивной тренировки как метода коррекции возрастных нарушений когнитивного контроля. Экспериментальная психология. 2009;2(3):78–91. [Velichkovskii BB. The cognitive training as a method of correction of age disorders of cognitive control. Eksperimental'- naya psikhologiya. 2009;2(3):78–91. (In Russ.)].

32. Hamann KF. Special ginkgo extract in cases of vertigo: a systematic review of randomised, double-blind, placebo controlled clinical examinations. HNO. 2007 Apr;55(4):258-63.

33. Orendors-Fraczkowska K, Pospiech L, Gawron W. Results of combined treatment for vestibular receptor impairment with physical therapy and Ginkgo biloba extract (Egb 761). Otolaryngol Pol. 2002;56(1):83-8.

34. Антоненко ЛМ, Бестужева НВ, Парфенов ВА. Диагностика и лечение головокружения в амбулаторной практике. Неврология, нейропсихиатрия, психосоматика. 2015;7(1):55-60. [Antonenko LM, Bestuzheva NV, Parfenov VA. Diagnosis and treatment of dizziness in outpatient practice. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2015;7(1): 55-60. (In Russ.)]. doi: 10.14412/2074-2711-2015-1-55-60

35. Антоненко ЛМ, Парфенов ВА. Специализированный подход к диагностике и лечению головокружения. Неврология, нейропсихиатрия, психосоматика. 2016;8(1):56-60. [Antonenko LM, Parfenov VA A specialized approach to diagnosing and treating vertigo. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2016;8(1):56-60. (In Russ.)].


For citation:


Antonenko L.M. Diagnosis, treatment, and rehabilitation in patients with dizziness and cognitive impairment. Neurology, Neuropsychiatry, Psychosomatics. 2017;9(3):76-80. (In Russ.) https://doi.org/10.14412/2074-2711-2017-3-76-80

Views: 239


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)